The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance.
about
The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes MellitusDoes Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?Lessons from mouse models of high-fat diet-induced NAFLDFatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicityMaintenance of metabolic homeostasis by Sestrin2 and Sestrin3Association of liver enzymes and computed tomography markers of liver steatosis with familial longevityInhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.Molecular nutrition research: the modern way of performing nutritional scienceRegulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivityH1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primatesTargeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.Intake of farmed Atlantic salmon fed soybean oil increases insulin resistance and hepatic lipid accumulation in miceInsulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructoseKetogenesis prevents diet-induced fatty liver injury and hyperglycemiaIntestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.Inducible Deletion of Protein Kinase Map4k4 in Obese Mice Improves Insulin Sensitivity in Liver and Adipose TissuesA weighty problem: metabolic perturbations and the obesity-cancer link.Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D.The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesAlleviation of Carbon-Tetrachloride-Induced Liver Injury and Fibrosis by Betaine Supplementation in ChickensMulti-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypesHepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signallingBiochemistry and pathophysiology of intravascular and intracellular lipolysis.Dietary walnut reduces hepatic triglyceride content in high-fat-fed mice via modulation of hepatic fatty acid metabolism and adipose tissue inflammation.Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2-/-) or obese (ob/ob) mice.Isolation and Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues.Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosisReversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis.Loss of CTRP5 improves insulin action and hepatic steatosisDe novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism.Mitochondrial substrate availability and its role in lipid-induced insulin resistance and proinflammatory signaling in skeletal muscle.
P2860
Q26766749-3FA6F32B-58EA-4DC9-A6ED-4FA817465AE8Q26798161-4B23239D-1069-4AB6-9F7A-497229ECA60BQ26829532-C3347300-F409-4139-87C8-7999543CE068Q27311488-73ED51B2-6CF3-4C4A-9F52-94AA2E27EF68Q28511498-F85682F8-D848-4334-B1CD-57686C18C153Q28540897-917EC893-9931-48BC-8272-B42B877B9B83Q30301111-8B3258B5-2FD6-450D-9EBC-8C91E359AB1DQ30458970-C44C81A2-A113-454B-8CFE-96A97E762598Q33621757-1F1E323E-71EF-4190-A79B-ED83E2BC1655Q33789323-B6A994C5-DFAE-46B5-B030-A6C01A599F5EQ33794679-FA766744-A334-4E63-8969-BFAE96B46449Q33825128-0C773208-2E89-4573-98F9-286D2A7704A8Q33913281-647A109A-D18E-46BB-979C-3980D6DD144BQ33959776-94295628-5E26-4BE1-B4A5-E511496DB56EQ34485836-709BEC2A-93E6-4A1F-96DD-BD7335B6F2C7Q34542315-F4B051FF-EBAA-4960-8841-727A8F583B1FQ34543004-EC360CDB-A52E-4191-AA16-521C4CC14E4DQ34571695-D2351B2B-CE16-4810-AEE2-3521053D766AQ34602496-DE3C24FB-6692-4FBE-AB87-38A9AEFBD77CQ35145496-E3A5FE20-91DA-423C-BBB3-C786B840DB0FQ35242565-1347466C-A639-4659-92BE-35A19C58B211Q35438444-387C9E6B-9D01-489D-998F-3D78B33B1E26Q35630861-1F4303F2-1523-4959-8785-C0513340AABBQ35685582-1CDB60FA-453E-4194-82F2-380FC6EE36A9Q35689545-2BD3A1C5-7526-43A6-83C4-F394D9434E52Q35690734-EA865499-2025-44AB-B06A-D6DCFF7493F0Q35811523-D54E3B3E-87CC-482D-8079-1A15C1488D8EQ36145165-F53486C3-7B08-412B-A52B-1AEBA24B96D6Q36354548-2841B7BA-4E86-4166-AE03-DFAC86B73FA3Q36591276-0DE67526-2302-4D7D-917F-F1893A2E3AE2Q36708030-9C666DF3-B4DD-4983-B548-F2A5CD7D6039Q36730200-4673171F-8057-4184-849A-7EFC8A42722EQ36731759-B6958D82-5ABB-469B-A7E0-92C8067453D1Q36826665-01809AC4-5021-43B6-9294-62E90E620802Q36847534-1D43C83C-A72E-4E6C-A341-55288A1AC9A9Q36974279-C825B3CD-AF2C-47FA-92F5-E17D90F8D281Q37070833-019F77CA-9EB7-412E-8736-3320680344E8Q37088326-3796E68E-530A-425C-A44C-7DFAE1CE0C17Q37093616-B552A451-BCF2-4A5B-AB72-8E4B2F2C10B4Q37193277-4F6627B9-437B-4539-8EC2-50821BDA6CBB
P2860
The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The problem of establishing re ...... nd hepatic insulin resistance.
@en
The problem of establishing re ...... nd hepatic insulin resistance.
@nl
type
label
The problem of establishing re ...... nd hepatic insulin resistance.
@en
The problem of establishing re ...... nd hepatic insulin resistance.
@nl
prefLabel
The problem of establishing re ...... nd hepatic insulin resistance.
@en
The problem of establishing re ...... nd hepatic insulin resistance.
@nl
P2093
P2860
P1433
P1476
The problem of establishing re ...... nd hepatic insulin resistance.
@en
P2093
Christopher B Newgard
Robert V Farese
Tobias C Walther
P2860
P304
P356
10.1016/J.CMET.2012.03.004
P577
2012-05-01T00:00:00Z